首页> 外文期刊>European Journal of Medicinal Chemistry: Chimie Therapeutique >Antiproliferative activity of diarylnaphthylpyrrolidine derivative via dual target inhibition
【24h】

Antiproliferative activity of diarylnaphthylpyrrolidine derivative via dual target inhibition

机译:双靶抑制的二芳基萘基吡咯烷衍生物的抗增殖活性

获取原文
获取原文并翻译 | 示例
           

摘要

Breast cancer is the second leading cause of deaths in women globally. Present communication deals with design and synthesis of a few diarylnaphthyls as possible anti-breast cancer agents. Among the thirty three representatives with significant antiproliferative activity compounds 23 and 50 were quite efficacious against human breast cancer cells. Compound 50 induced apoptosis in both MCF-7 and MDA-MB-231 cells and exerted S phase and G2/M phase arrest respectively via distinct mechanistic pathways. It showed moderate microtubule destabilization. Further, it exhibited DNA topoisomerase-II inhibition effect in MCF-7 cells. It was well tolerable and found safe up to 300 mg/kg dose in Swiss albino mice. The dual action antiproliferative effect of compound 50 is quite interesting and warrants for future development. (C) 2019 Elsevier Masson SAS. All rights reserved.
机译:乳腺癌是全球妇女死亡的第二个主要原因。 目前的沟通与一些二芳基碱基的设计和合成作为可能的抗乳腺癌药剂。 在具有显着抗增殖活性的三十三个代表中,23和50的抗抗原性化合物对人乳腺癌细胞相当有效。 化合物50分别通过不同的机械途径诱导MCF-7和MDA-MB-231细胞中的细胞凋亡,并分别施加S相和G2 / M相阻滞。 它显示出中度微管稳定化。 此外,它在MCF-7细胞中表现出DNA TOPOISOMERASE-II抑制作用。 它是良好的耐受性,并且在瑞士白化小鼠中发现了300毫克/千克的剂量。 化合物50的双重作用抗增殖效应是非常有趣的,并且未来发展的认股权证是非常有趣的。 (c)2019年Elsevier Masson SAS。 版权所有。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号